GR3023719T3 - Trifluoromethylketone tripeptide derivatives - Google Patents

Trifluoromethylketone tripeptide derivatives

Info

Publication number
GR3023719T3
GR3023719T3 GR970401361T GR970401361T GR3023719T3 GR 3023719 T3 GR3023719 T3 GR 3023719T3 GR 970401361 T GR970401361 T GR 970401361T GR 970401361 T GR970401361 T GR 970401361T GR 3023719 T3 GR3023719 T3 GR 3023719T3
Authority
GR
Greece
Prior art keywords
alkyl
carboxy
trifluoromethylketone
phenyl
morpholino
Prior art date
Application number
GR970401361T
Other languages
Greek (el)
English (en)
Inventor
Keiji Hemmi
Ichiro Shima
Keisuke Imai
Hirokazu Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909028231A external-priority patent/GB9028231D0/en
Priority claimed from GB919119713A external-priority patent/GB9119713D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of GR3023719T3 publication Critical patent/GR3023719T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Magnetically Actuated Valves (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
GR970401361T 1990-12-31 1997-06-10 Trifluoromethylketone tripeptide derivatives GR3023719T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909028231A GB9028231D0 (en) 1990-12-31 1990-12-31 Trifluoromethylketone derivatives,processes for preparation thereof and use thereof
GB919119713A GB9119713D0 (en) 1991-09-16 1991-09-16 Trifluoremethylketone derivatives, processes for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
GR3023719T3 true GR3023719T3 (en) 1997-09-30

Family

ID=26298196

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401361T GR3023719T3 (en) 1990-12-31 1997-06-10 Trifluoromethylketone tripeptide derivatives

Country Status (19)

Country Link
US (2) US5296591A (OSRAM)
EP (1) EP0494071B1 (OSRAM)
JP (1) JPH0699378B2 (OSRAM)
KR (1) KR100192991B1 (OSRAM)
CN (1) CN1040003C (OSRAM)
AT (1) ATE151775T1 (OSRAM)
AU (1) AU641577B2 (OSRAM)
CA (1) CA2058560C (OSRAM)
DE (1) DE69218977T2 (OSRAM)
DK (1) DK0494071T3 (OSRAM)
ES (1) ES2099755T3 (OSRAM)
FI (1) FI106379B (OSRAM)
GR (1) GR3023719T3 (OSRAM)
HU (2) HU210263B (OSRAM)
IE (1) IE914360A1 (OSRAM)
MX (1) MX9102612A (OSRAM)
NO (1) NO309274B1 (OSRAM)
RU (1) RU2073684C1 (OSRAM)
SG (1) SG50457A1 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1995033762A1 (en) * 1994-06-02 1995-12-14 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
DK0762887T3 (da) * 1994-06-02 2002-01-14 Merrell Pharma Inc Acylerede enolderivater som prodrugs for elastase-hæmmere
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
US20020045231A1 (en) * 1999-02-02 2002-04-18 Napper Andrew D. Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
CN1407902A (zh) * 1999-10-12 2003-04-02 藤泽药品工业株式会社 难治性创伤的治疗剂
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases
DE10219464A1 (de) 2002-04-30 2003-11-13 Focke & Co Zigarettenpackung
SE0202462D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
WO2007140117A1 (en) * 2006-05-23 2007-12-06 Irm Llc Compounds and compositions as channel activating protease inhibitors
US20090202514A1 (en) * 2006-08-25 2009-08-13 Hiroyuki Yoneyama Agents for improving chronic obstructive pulmonary diseases
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
WO2011046954A1 (en) * 2009-10-13 2011-04-21 Ligand Pharmaceuticals Inc. Hematopoietic growth factor mimetic small molecule compounds and their uses
ES2645847T3 (es) * 2013-05-08 2017-12-11 Kissei Pharmaceutical Co., Ltd. Derivado de glicinamida alfa-sustituido
CN104650016A (zh) * 2015-01-29 2015-05-27 武汉大学 拟三肽类化合物及其制备方法
CN113693965B (zh) * 2016-06-24 2024-03-29 宝丽化成工业有限公司 用于改善皱纹的皮肤外用剂
WO2019098010A1 (ja) 2017-11-15 2019-05-23 ポーラ化成工業株式会社 油性組成物
CN119241385B (zh) * 2024-11-29 2025-03-25 江西师范大学 β-酰氧基烯酰胺衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof

Also Published As

Publication number Publication date
CA2058560C (en) 2000-12-12
MX9102612A (es) 1992-06-01
DE69218977D1 (de) 1997-05-22
ES2099755T3 (es) 1997-06-01
SG50457A1 (en) 1998-07-20
US5430025A (en) 1995-07-04
HU211943A9 (en) 1996-01-29
HUT60507A (en) 1992-09-28
DE69218977T2 (de) 1997-08-07
NO920035L (no) 1992-07-01
RU2073684C1 (ru) 1997-02-20
HU914153D0 (en) 1992-03-30
CN1040003C (zh) 1998-09-30
CA2058560A1 (en) 1992-07-01
KR920011988A (ko) 1992-07-25
AU8985391A (en) 1992-07-02
US5296591A (en) 1994-03-22
FI915996L (fi) 1992-07-01
ATE151775T1 (de) 1997-05-15
EP0494071A3 (en) 1993-05-05
IE914360A1 (en) 1992-07-01
KR100192991B1 (ko) 1999-06-15
FI106379B (fi) 2001-01-31
JPH0699378B2 (ja) 1994-12-07
JPH04297446A (ja) 1992-10-21
NO920035D0 (no) 1992-01-02
EP0494071A2 (en) 1992-07-08
HU210263B (en) 1995-03-28
DK0494071T3 (OSRAM) 1997-05-12
NO309274B1 (no) 2001-01-08
CN1063108A (zh) 1992-07-29
AU641577B2 (en) 1993-09-23
EP0494071B1 (en) 1997-04-16
FI915996A0 (fi) 1991-12-19

Similar Documents

Publication Publication Date Title
DK0494071T3 (OSRAM)
GR3032311T3 (en) Stilbene derivatives and pharmaceutical compositions containing them
AU6052594A (en) New heterocyclic compounds
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
MY119820A (en) Guanidine mimics as factor xa inhibitors
GR3021182T3 (en) New peptide compound and a process for the preparation thereof
TW274552B (OSRAM)
IL106445A0 (en) 4-substituted 1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
AU8491691A (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
EP0276101A3 (en) Substituted peptide derivatives
DE69330601D1 (de) Serotoninergische ergolin derivate
CA2262791A1 (en) Amino acid ester containing azole antifungals
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
WO1987004435A3 (en) Xanthine compounds
FR2781482B1 (fr) Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent